By Melissa Lipman ( April 11, 2013, 8:15 PM EDT) -- Former Federal Trade Commission Chairman Jon Leibowitz predicted Thursday that the U.S. Supreme Court would take the middle road on pay-for-delay, likely overturning a ruling that the pharmaceutical patent settlements are generally legal without endorsing the antitrust watchdog's request for a near-ban on the arrangements....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.